Suppr超能文献

影响患者对主动监测接受度和依从性的因素。

Factors influencing patients' acceptance and adherence to active surveillance.

作者信息

Penson David F

机构信息

Center for Surgical Quality and Outcomes Research, Vanderbilt University Medical Center, 2525 West End Ave, Nashville, TN 37203-1738, USA.

出版信息

J Natl Cancer Inst Monogr. 2012 Dec;2012(45):207-12. doi: 10.1093/jncimonographs/lgs024.

Abstract

Clinical decision making in localized prostate cancer is a complicated, multidimensional process in which men often consider their own personal preferences, the advice of their healthcare providers, the opinions of their family and friends, and outside information sources. They synthesize all of this within the framework of their own unique socioeconomic situation, their social support network, and their preconceived impressions of their health and the health-care system. This is particularly germane when considering factors that influence a patient's acceptance of and adherence to active surveillance (AS). We propose a conceptual framework based on a previously described systematic-heuristic theoretical model of decision making in this setting. We identify a number of factors that patients systematically prioritize when considering AS. These include desire for cancer control or cure, age at diagnosis, and concern regarding side effects of treatment. The way patients value these factors and effectively decide on treatment is influenced by more heuristic factors, including physician recommendation, opinion of friends and family members, and overall decision uncertainty. These heuristic factors also play an important role in adherence when a patient elects AS. Finally, some of the factors, particularly the heuristic ones, are potentially modifiable and may serve as targets for future interventions to increase acceptance of and adherence to AS.

摘要

局限性前列腺癌的临床决策是一个复杂的多维度过程,在此过程中,男性通常会考虑自己的个人偏好、医疗服务提供者的建议、家人和朋友的意见以及外部信息来源。他们在自身独特的社会经济状况、社会支持网络以及对自身健康和医疗系统的先入之见的框架内综合考虑所有这些因素。在考虑影响患者接受和坚持主动监测(AS)的因素时,这一点尤为重要。我们基于先前描述的该情况下决策的系统启发式理论模型提出了一个概念框架。我们确定了患者在考虑AS时系统地优先考虑的一些因素。这些因素包括对癌症控制或治愈的渴望、诊断时的年龄以及对治疗副作用的担忧。患者评估这些因素并有效决定治疗的方式受到更多启发式因素的影响,包括医生的建议、朋友和家庭成员的意见以及总体决策不确定性。当患者选择AS时,这些启发式因素在坚持方面也起着重要作用。最后,一些因素,特别是启发式因素,可能是可改变的,并且可能成为未来干预措施的目标,以提高对AS的接受度和坚持度。

相似文献

1
Factors influencing patients' acceptance and adherence to active surveillance.
J Natl Cancer Inst Monogr. 2012 Dec;2012(45):207-12. doi: 10.1093/jncimonographs/lgs024.
2
Patient acceptance of active surveillance as a treatment option for low-risk prostate cancer.
BJU Int. 2011 Dec;108(11):1787-93. doi: 10.1111/j.1464-410X.2011.10200.x. Epub 2011 Apr 20.
3
Factors influencing treatment decision making and information preferences of prostate cancer patients on active surveillance.
Patient Educ Couns. 2012 Jun;87(3):369-74. doi: 10.1016/j.pec.2011.11.009. Epub 2011 Dec 15.
5
An evidence review of active surveillance in men with localized prostate cancer.
Evid Rep Technol Assess (Full Rep). 2011 Dec(204):1-341.
7
Patient and disease factors affecting the choice and adherence to active surveillance.
Curr Opin Urol. 2015 May;25(3):272-6. doi: 10.1097/MOU.0000000000000154.

引用本文的文献

4
Patients' Reaction to Diagnosis with Thyroid Cancer or an Indeterminate Thyroid Nodule.
Thyroid. 2021 Apr;31(4):580-588. doi: 10.1089/thy.2020.0233. Epub 2020 Nov 4.
8
Selecting Active Surveillance: Decision Making Factors for Men with a Low-Risk Prostate Cancer.
Med Decis Making. 2019 Nov;39(8):962-974. doi: 10.1177/0272989X19883242. Epub 2019 Oct 21.
10
ESTIMATING AND COMPARING CANCER PROGRESSION RISKS UNDER VARYING SURVEILLANCE PROTOCOLS.
Ann Appl Stat. 2018 Sep;12(3):1773-1795. doi: 10.1214/17-AOAS1130. Epub 2018 Sep 11.

本文引用的文献

1
Treatment decision-making for localized prostate cancer: what younger men choose and why.
Prostate. 2012 Jan;72(1):58-64. doi: 10.1002/pros.21406. Epub 2011 Apr 25.
2
Patient acceptance of active surveillance as a treatment option for low-risk prostate cancer.
BJU Int. 2011 Dec;108(11):1787-93. doi: 10.1111/j.1464-410X.2011.10200.x. Epub 2011 Apr 20.
3
Provider and partner interactions in the treatment decision-making process for newly diagnosed localized prostate cancer.
BJU Int. 2011 Sep;108(6):851-6; discussion 856-7. doi: 10.1111/j.1464-410X.2010.09945.x. Epub 2011 Jan 18.
4
The needs for men undergoing active surveillance (AS) for prostate cancer: results of a focus group study.
J Clin Nurs. 2011 Feb;20(3-4):581-6. doi: 10.1111/j.1365-2702.2010.03489.x.
5
Factors that influence patient enrollment in active surveillance for low-risk prostate cancer.
Urology. 2011 Mar;77(3):588-91. doi: 10.1016/j.urology.2010.10.039. Epub 2011 Jan 7.
6
Early prostate cancer--which treatment do men prefer and why?
BJU Int. 2011 Jun;107(11):1762-8. doi: 10.1111/j.1464-410X.2010.09833.x. Epub 2010 Nov 17.
8
The 2010 NCCN clinical practice guidelines in oncology on prostate cancer.
J Natl Compr Canc Netw. 2010 Feb;8(2):145. doi: 10.6004/jnccn.2010.0010.
9
Time trends and local variation in primary treatment of localized prostate cancer.
J Clin Oncol. 2010 Mar 1;28(7):1117-23. doi: 10.1200/JCO.2009.26.0133. Epub 2010 Feb 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验